Related Experiment Video
Updated: Aug 12, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Incidence, Predictors, and Clinical Outcomes of Device-Related Thrombus in the Amulet IDE Trial
Boris Schmidt1, Jens Erik Nielsen-Kudsk2, Christopher R Ellis3
1Cardioangiologisches Centrum Bethanien, Frankfurt, Germany.
Insights
Device-related thrombus (DRT) after left atrial appendage occlusion (LAAO) is uncommon. Early DRT is associated with dual-mechanism devices, while late DRT is linked to single-mechanism devices, with increased mortality risk for DRT patients.
Area of Science:
- Cardiology
- Medical Devices
- Thrombosis
Background:
- Device-related thrombus (DRT) is a complication of left atrial appendage occlusion (LAAO).
- Limited data exist on DRT rates and outcomes from randomized trials following LAAO.
Purpose of the Study:
- To investigate the incidence, predictors, and clinical outcomes of DRT after LAAO.
- To compare DRT characteristics between dual and single occlusive mechanism devices.
Main Methods:
- Analysis of the Amulet IDE trial data, comparing Amulet (dual occlusive mechanism) and Watchman (single occlusive mechanism) devices.
- Follow-up of 903 patients with Amulet and 885 patients with Watchman devices for 18 months.
- Assessment of DRT using transesophageal echocardiography.
Main Results:
- Overall DRT incidence was 3.9% (3.4% dual, 4.8% single mechanism).
- Early DRT (≤45 days) was more common with dual-mechanism devices; late DRT (>45 days) with single-mechanism devices.
- Predictors of DRT included atrial fibrillation during procedure, female sex, and older age. Patients with DRT faced higher cardiovascular mortality risk.
Conclusions:
- DRT incidence following LAAO is low, with distinct timing patterns for dual and single occlusive mechanism devices.
- Further investigation into the increased cardiovascular mortality risk associated with DRT is warranted.
- The study provides insights into DRT management and device selection in LAAO procedures.
Background:
Device-related thrombus (DRT) following left atrial appendage occlusion (LAAO) can lead to adverse clinical outcomes. DRT rates and outcomes from randomized trials are limited.
Objectives:
This analysis investigated the incidence, predictors, and clinical outcomes of DRT following LAAO in the Amulet IDE (AMPLATZER Amulet LAA Occluder Trial) trial.
Methods:
Successful implants occurred in 903 patients with an Amulet occluder (dual occlusive mechanism device) and 885 patients with a Watchman device (single occlusive mechanism device). These patients were then followed through 18 months and DRT was assessed by transesophageal echocardiography.
Results:
The overall incidence of DRT was 3.9% (n = 70) with 3.4% (n = 30) in dual occlusive mechanism device patients and 4.8% (n = 40) in single occlusive mechanism device patients. Most DRTs (n = 19 of 31) were identified early (≤45 days) on the dual occlusive mechanism device, whereas most of the DRTs (n = 31 of 42) were identified late (>45 days) on the single occlusive mechanism device. Strong predictors of DRT included atrial fibrillation at time of procedure (HR: 2.44; 95% CI: 1.42-4.22; P < 0.01), female sex (HR: 1.65; 95% CI: 1.01-2.71; P = 0.04), and older age (HR: 1.04; 95% CI: 1.01-1.08; P = 0.02). There were no stroke events following DRT in the dual occlusive mechanism device group and 3 stroke events following DRT in the single occlusive mechanism device group. Patients with DRT were at a greater risk for cardiovascular mortality compared with non-DRT patients (8.7% vs 3.9%; HR: 2.33; 95% CI: 1.01-5.39; P = 0.04).
Conclusions:
Incidence of DRT following LAAO was low. Early DRTs are seen with the dual occlusive mechanism device and late DRTs are seen with the single occlusive mechanism device. Increased cardiovascular mortality risk in patients with DRT should be further investigated. (AMPLATZER Amulet LAA Occluder Trial; NCT02879448).
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins

